1 – 21 of 21
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Outlining recent updates on influenza therapeutics and vaccines : A comprehensive review
(
- Contribution to journal › Scientific review
-
Mark
Factors associated with COVID-19 vaccine uptake among south African health care workers
(
- Contribution to journal › Article
- 2023
-
Mark
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains
(
- Contribution to journal › Article
-
Mark
The exposome and immune health in times of the covid-19 pandemic
(
- Contribution to journal › Scientific review
-
Mark
Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization : A situation analysis of Cameroon
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Advanced biotechnology-based therapeutics
2021) p.53-77(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months
(
- Contribution to journal › Article
-
Mark
COVID-19 herd immunity in the absence of a vaccine : an irresponsible approach
(
- Contribution to journal › Article
- 2020
-
Mark
Panel 1: Biotechnology, biomedical engineering and new models of otitis media
2020) 20th International Symposium on Recent Advances in Otitis Media In International Journal of Pediatric Otorhinolaryngology 130(1).(
- Contribution to journal › Article
-
Mark
Pharmaceutical lobbying and pandemic stockpiling : A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19
(
- Contribution to journal › Article
- 2019
-
Mark
Applications of nanodiamonds in the detection and therapy of infectious diseases
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Differing rates of antibody acquisition to merozoite antigens in malaria : Implications for immunity and surveillance
(
- Contribution to journal › Article
-
Mark
Panel 6 : Vaccines
(
- Contribution to journal › Article
- 2016
-
Mark
Seroprevalencia de anticuerpos a virus del sarampión, rubeola, parotiditis, hepatitis B y los tres serotipos de poliovirus, en niños de Quindío, Colombia
(
- Contribution to journal › Article
- 2013
-
Mark
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.
(
- Contribution to journal › Article
- 2012
-
Mark
Small Randomized Trial Among Low-Birth-Weight Children Receiving Bacillus Calmette-Guerin Vaccination First Health Center Contact
(
- Contribution to journal › Article
- 2008
-
Mark
Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.
(
- Contribution to journal › Article
- 2005
-
Mark
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
(
- Contribution to journal › Article
- 2004
-
Mark
Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
(
- Contribution to journal › Article